Skip to content
Recall Observatory FDA recall evidence

Drug product

MAXILOSS Weight Advanced, 225 mg proprietary blend of herbs, supplied in 36 count capsules in Green & Blue Boxes, Formulated and distributed by Olaax Corp, Lakeland, FL

D-600-2013

February 12, 2013

Class I

Product summary

Firm
OLAAX International
Event
Event 64409
Status
Terminated
Classification
Class I
Quantity
600 boxes
Official record key
drug-enforcement:D-600-2013

Official wording

Reason: Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.

Code information: All Lots

Distribution pattern: Nationwide, Puerto Rico and Venezuela and Bolivia

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.

Field note

Send feedback

We'll only use this to respond to your feedback.